Latest article
The 2025 Non-Financial Corporate Capitalization Landscape: New Records and a Historic Shift in Leadership
The unprecedented surge of Vingroup's ecosystem marked a pivotal moment in the 2025 market capitalization rankings, reshaping the power dynamics among non-financial conglomerates.
Chinese Pharmaceutical Giant Acquires Imexpharm
On January 15th, Imexpharm Pharmaceutical JSC (HOSE: IMP) announced receiving a public tender offer for IMP shares from Lian SGP Holding Pte. Ltd., an indirectly wholly-owned subsidiary of Chinese pharmaceutical giant Livzon Pharmaceutical Group. Notably, the registered purchase volume exceeds the figure previously announced in May 2025.
Technical Analysis for the Afternoon Session of January 15th: A Sharp Correction
The VN-Index experienced a sharp correction, accompanied by a sell signal from the Stochastic Oscillator, indicating heightened short-term risk. Similarly, the HNX-Index is in a comparable state, currently finding support at the Middle line of the Bollinger Bands.
